WHITNEY CHASE: Open Payments
NPI 1821500984 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,350 in 14 payments from 11 companies in 2025. Trend: 2023 $1,831 · 2024 $1,579 · 2025 $1,350
Food & beverage: $1,235Consulting: $115
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $218 |
| Janssen Scientific Affairs, LLC | 2 | $213 |
| Amgen Inc. | 1 | $139 |
| Incyte Corporation | 1 | $125 |
| Merck Sharp & Dohme LLC | 1 | $125 |
| Exelixis Inc. | 1 | $122 |
| Gilead Sciences, Inc. | 1 | $111 |
| PFIZER INC. | 1 | $100 |
| Ipsen Biopharmaceuticals, Inc | 1 | $85 |
| Genmab U.S., Inc. | 2 | $83 |
Products named: TECVAYLI, IMDELLTRA (AMG757), Niktimvo, WELIREG, CABOMETYX, RYBREVANT, TALVEY, Trodelvy.
Industry payments across TN — which companies pay providers there.
